Charged Alpha Stock Encyclopedia
⚡ Charged Alpha — The S&P 500 Stock Encyclopedia Data-driven deep dives into every stock in the S&P 500 after every earnings report. Each episode breaks down one company from open to close: what they do, how the numbers look, what Wall Street thinks, the bull case, the bear case. 🛠️ Check out our free beginner-friendly screening tools for stocks, ETFs, options, crypto, bonds, REITs & more at https://chargedalpha.com — no signup, no paywall. 📊 What you get in every episode: Company overview & competitive moat Full financial breakdown — valuation, revenue, margins, cash flow Analyst consensus & price targets Bull case vs. bear case Peer comparison, options flow & insider activity Key metrics to watch ⚠️ Not financial advice. For educational purposes only. Episodes are researched, written, and produced using AI-assisted tools. All data aggregated from publicly available sources. #stocks #investing #S&P500 #stockanalysis #chargedalpha #financialdata #earningsreport #earnings
Episodes

Aug 15, 2026
Aug 15, 2026
14 min
Boost Run Inc. (BRUN) Q2 2026 — Q2 2026 (three months ended June 30; the 8-K Item 2.02 hit EDGAR at 08:46 ET on Friday August 14, so August 14 is the reaction session). The stock gapped to 26.25 USD against a 22.55 USD prior close, ran to 26.90 USD (+19.3 pct), then fell to 21.93 USD and closed 22.93 USD - just +1.69 pct, giving back 91 pct of the gain on 8.3x normal volume.
Boost Run's first earnings as a public company produced a 75.0M USD GAAP net loss and a 1.67 USD loss per diluted Class A share - and almost none of that is an operating event. 55.7M USD of it (74 pct) is a one-time non-cash deferred tax recognised when the operating LLC converted to a C-corporation at the de-SPAC closing. Strip it, plus stock compensation and debt extinguishment, and the adjusted net loss is 10.8M USD and EBITDA is POSITIVE. Revenue grew 270 pct, organically. The bears read this print wrong. We are still sellers, because the 1.9bn USD backlog implies 1.36bn-1.58bn USD of 2026 capex on the company's own ratio - against 120.2M USD of cash and 100.0M USD of equity.
THE CALL: SELL (3/5, MODERATE - REAL DEMAND, UNFUNDED PLAN) — base-case value ~$17.02 vs ~$22.93 today.
KEY METRICS:
- CALL: SELL, 3/5. Fair value 18.00 USD vs the 22.93 USD close on August 14 - about 21 pct BELOW the tape and 60 pct below the 45.00 USD Street consensus. Scenario-weighted on year-end ARR: bear 200M at 4.0x = 5.73 USD (25 pct), base 300M at 6.5x = 17.02 USD (50 pct), bull 400M at 9.0x = 32.22 USD (25 pct).
- REVENUE: 31.1M USD, up 270 pct from 8.4M USD, and organic - clusters coming online, not an acquisition. Six-month revenue 42.1M USD vs 12.6M USD. NOTE: the data feeds carry 18.0M USD for this quarter and are 42 pct light; 42.1M less the 11.0M first quarter reproduces 31.1M exactly.
- THE LOSS: GAAP net loss 75.0M USD, of which 55.7M USD (74 pct) is a ONE-TIME NON-CASH deferred tax under ASC 740-10-25-32, booked when the LLC became a C-corporation at the May 8 de-SPAC close. Adjusted net loss 10.8M USD. EBITDA POSITIVE 3.9M USD; adjusted EBITDA 12.3M USD (40 pct margin).
- PER SHARE: GAAP diluted loss 1.67 USD per Class A share; adjusted 0.24 USD - both on 45,032,269 diluted weighted-average Class A shares. The feeds print 0.48 USD on TWO rows, a duplication defect, matching neither. Dual class: 47.3M Class A and 29.5M Class B, 76.8M total at June 30.
- THE CASH FLOW ILLUSION: first-half operating cash flow was 114.2M USD, but 112.9M USD of it (99 pct) is an increase in CUSTOMER DEPOSITS - prepayments for compute not yet delivered. The company's own deck says it should not be run-rated. Underlying: 1.3M USD.
- THE FUNDING GAP: the 1.9bn USD backlog at the company's own 1.2x-1.4x contracted-value-to-capex ratio implies 1.36bn-1.58bn USD of 2026 capex. Against 120.2M USD cash, 100.0M USD equity, 642.2M USD liabilities, 238.1M USD finance leases and a 0.87 current ratio.
- BACKLOG AND ARR: total contract value 1.9bn USD as of July 31, over 1bn USD signed in the quarter. ARR tripled from 30M to 145M USD against a 400M USD year-end target - a further 2.8x in six months. Six data centres live, three more coming, 253MW of power.
- GOVERNANCE FLAG: Boost Run did NOT file its 10-Q. It filed a Form 12b-25 late notice the same morning it reported - the SECOND consecutive quarter. Every figure here is from the unaudited 8-K earnings deck, not a filed financial statement.
What to watch: UP: the late 10-Q lands clean with low customer concentration; year-end ARR tracks toward 400M USD; lease financing stays open. DOWN: a shelf or at-the-market equity programme; ARR growth below a 2.8x six-month pace; a customer-concentration disclosure showing the backlog leans on a few names.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
Cogent Biosciences, Inc. (COGT) Q2 2026 — Q2 2026 (three months ended June 30; the 8-K hit EDGAR at 08:06 ET on Monday August 10, so August 10 is the reaction session): no revenue at all, net loss 96.4M USD, GAAP loss per share 0.52 USD vs a 0.55 bar. The print moved the stock just 2.03 pct on 0.68x volume - then a 400M USD equity program was filed at 17:17 the same day and the next session fell 6.81 pct.
Cogent has won. PEAK is the first positive Phase 3 in second-line GIST in over twenty years, three NDAs are filed and two PDUFA dates land inside twenty weeks. The stock is up 249 pct in a year. And at 17:17 on the afternoon it reported, Cogent registered another 400M USD of stock.
THE CALL: HOLD (3/5, MODERATE - GREAT DRUG, FULL PRICE) — base-case value ~$26.14 vs ~$37.93 today.
KEY METRICS:
- CALL: HOLD, 3/5. Fair value 26.48 USD vs the 37.93 USD close on August 14 - about 30 pct BELOW the tape, and 45 pct below the 47.80 USD Street consensus. With no revenue and no earnings to put a multiple on, this is a probability-weighted NPV: bear 20.47, base 26.14, bull 33.15, weighted 25/50/25. Even the bull case sits below the price.
- THE QUARTER (ended June 30, 2026): NO revenue line at all - the income statement opens at operating expenses. R and D 70.8M USD, up 13.8 pct. G and A 31.8M USD, up 137.9 pct on the commercial build. Net loss 96.4M USD, up 31.1 pct. Loss per share 0.52 USD via the TWO-CLASS method; a flat division gives 0.56 and is wrong.
- THE ANGLE - THE PRICE OF THE WIN: on November 7, 2025, the Friday BEFORE the PEAK read-out, Cogent lifted its ATM ceiling from 75M to 300M USD. The Monday after, the stock rose 119 pct in one session. Eight days later it sold 230.0M USD of 1.625 pct converts at 44.95 USD with NO capped call - then filed a NEW 400M USD program on print day.
- THE DILUTION, FULLY COUNTED: the 10-Q cover shows 173,524,982 shares at August 6, yet the screens print a 6,481M USD market cap - implying only 170.9M. Add preferred as-converted, 5.12M convert shares, 27.11M options at 11.08 USD, restricted stock and the new program: 235.6M claims, 35.8 pct more paper than the screen shows.
- THE EVIDENCE IS GENUINELY STRONG: PEAK Phase 3 in second-line GIST gave median PFS of 16.5 months vs 9.2 on sunitinib alone, hazard ratio 0.50, and a 46 pct response rate vs 26 pct. APEX in advanced systemic mastocytosis: 65 pct response. But overall survival in PEAK is still IMMATURE, and survival is what payers price.
- CASH AND RUNWAY: 792.3M USD at June 30 plus 73.6M raised since gives 865.9M USD pro forma, against 230.0M USD of converts. Operating burn was 164.2M USD across the half - 82.1M a quarter, or 10.5 quarters. Management guides into late 2028, but that assumes burn never rises through a launch. Runway and dilution are the same decision.
What to watch: UP: approval on November 30 (GIST) and December 30 (non-advanced SM); the avapritinib-switch SUMMIT extension reading out by year end; the equity program left undrawn into strength. DOWN: a complete response letter on either filing; the 400M USD program drawn hard after approval; AYVAKIT holding share.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
Tencent Music Entertainment Group (TME) Q2 2026 — Q2 2026 (three months ended June 30; released before the open on Tuesday August 11, so August 11 is the reaction session): total revenue RMB 8,933M (US$1,317M) vs a US$1,300M bar, non-IFRS EPS US$0.25 per ADS vs a US$0.24 bar - a beat on both lines, and the stock still fell 11.9%.
Tencent Music beat on revenue and earnings and fell 11.9% anyway. Revenue rose RMB 491M - and RMB 407M of that came from Ximalaya, acquired May 18. Organic growth was 1.0%. The metrics that would prove otherwise were withdrawn in March.
THE CALL: HOLD (3/5, MODERATE - CHEAP BUT UNAUDITABLE) — base-case value ~$11.33 vs ~$8.84 today.
KEY METRICS:
- CALL: HOLD, 3/5. Fair value $11.38 vs the $8.84 close on August 14, about 29% higher - and we are still not buyers. This is an EV/owner-earnings grid: non-IFRS profit less all stock compensation and half the deal amortisation. Bear $8.58 (8.0x), base $11.33 (10.5x), bull $14.27 (13.0x), weighted 25/50/25. Headline Street target is $15.22, but targets written since the print average $11.50.
- THE QUARTER (ended June 30, 2026; IFRS, in RMB at 6.7851/USD): revenue RMB 8,933M (US$1,317M), up 5.8%. Music related services RMB 7,605M, up 11.0%. Social entertainment RMB 1,328M, down 16.4%. Gross margin 44.2%. IFRS diluted EPS per ADS RMB 1.57 (US$0.23); non-IFRS RMB 1.70 (US$0.25). One ADS = two Class A shares, per the 6-K.
- THE ANGLE - 83% OF THE GROWTH WAS ACQUIRED: revenue rose RMB 491M, and the release states Ximalaya, consolidated from May 18 (about six weeks), contributed RMB 407M. Strip it and organic growth was 1.0%. Music related services grew 11.0% reported, 5.0% ex-Ximalaya. The six-week stub annualises near RMB 3.4bn, so Q3 reported growth improves and means less.
- AND THE METRICS THAT WOULD CHECK IT ARE GONE: on March 17, 2026, under Planned Disclosure Change, TME discontinued quarterly online-music MAU, paying users and ARPPU, reporting total paying users annually instead. Last disclosed: 127.4M paying users, ARPPU RMB 11.9 (flat two quarters), MAU 528M, down 5.0% and falling faster. Four downgrades followed within days.
- THE CASH IS SMALLER THAN THE HEADLINE: cash, deposits and short-term investments rose 16.2% to RMB 44,222M (US$6,518M). But borrowings went from zero at December 31 to RMB 13,139M for Ximalaya; total debt is RMB 16,529M. Net cash is RMB 27,693M (US$4,082M), DOWN 19.8% in six months. Operating cash flow was strong at RMB 2,864M, up 74.8%.
- THE BUYBACK DOES NOT SURVIVE DECOMPOSITION: TME repurchased 43.5M ADSs for US$400.0M at an average US$9.2 - yet weighted-average basic ADSs ROSE 2.2%, to 1,564.2M. Treasury shares rose RMB 2,725M while paid-in capital rose RMB 5,014M: roughly twice as much stock issued as retired. Tencent holds 93.6% of the votes in this Cayman-incorporated VIE.
What to watch: UP: the annual paying-user figure showing the base compounded through the blackout; Q3 separating Ximalaya from the organic base; the ADS count finally shrinking. DOWN: another quarter of ~1% organic growth; net cash falling again; a year-end disclosure with no ARPPU beside it.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
California Resources Corporation (CRC) Q2 2026 — Q2 2026 (three months ended June 30; released before the open on Monday August 10, so August 10 is the reaction session): total revenue $1,297M vs a $960M bar, GAAP EPS $5.76, adjusted EPS $0.99 vs a $1.36 bar - a 27% miss. The stock gapped down 1.6%, then closed up 3.21%, and finished August 14 at $53.31.
California Resources printed a 35% revenue beat and a 27% adjusted EPS miss in the same release, and both came out of the commodity derivative book. Marking the open hedge position to market created a $370M non-cash gain booked inside revenue; settling the hedges that expired cost $165M in cash. Strip the mark and revenue is $1,092M - a 13.7% beat, not 35%.
THE CALL: HOLD (3/5, MODERATE - CHEAP ON CASH, FLAT ON OPERATIONS) — base-case value ~$56.43 vs ~$53.31 today.
KEY METRICS:
- CALL: HOLD, 3/5. Fair value $57.84 vs the $53.31 close on August 14, about 8% higher. This is an EV/adjusted-EBITDAX grid, not an earnings multiple, because GAAP profit here is dominated by derivative marks. Bear $37.85 ($1,150M at 4.0x), base $56.43 ($1,250M at 5.0x), bull $80.64 ($1,400M at 6.0x), weighted 25/50/25. The Street is Buy - 18 buy, 5 hold, 1 sell - with an $80.00 average target. We are 28% below them.
- THE QUARTER (three months ended June 30, 2026): total operating revenues $1,297M vs a $960M consensus. Revenue BEFORE commodity derivatives - the company's own line - was $1,092M, up 33% from $821M. GAAP net income $514M, diluted EPS $5.76 vs $1.92. Adjusted net income $88M, adjusted EPS $0.99 vs a $1.36 bar and vs $1.10 a year ago. Zacks put the bar at $1.31 and the miss at 24%.
- THE ANGLE - ONE HEDGE BOOK MADE BOTH HEADLINES: marking the open position to market produced a $370M non-cash gain on oil plus $20M on gas, and the net $205M lands inside REVENUE. That entry is the whole difference between a 13.7% beat and the 35% one the feeds printed. Settling expired contracts cost $165M cash. Of the $5.76 GAAP EPS, $4.77 came back out in the adjustment column.
- THE BARREL SHOWS IT WITHOUT ACCOUNTING: CRC realized $91.55 a barrel WITHOUT derivative settlements - 95% of the $96.87 Brent average. WITH hedge settlements it kept $76.43, only 79% of Brent, vs 100% a year ago. That is $15.12 a barrel handed to the counterparty on 120 thousand barrels a day. Natural gas realized $1.84 vs $3.56 in Q1.
- THE OPERATING TRUTH: adjusted EBITDAX $338M vs $324M, up only 4.3%, on production up 8.8% to 149 MBoe/d and after absorbing the Berry merger that closed December 18, 2025. Per barrel that is a DECLINE, $25.95 to $24.94. Overhead per barrel rose 13.9% even as management captured $103M of annualized Berry synergies. First-half free cash flow fell 66%, $240M to $82M, on capital up 152%.
- THE GUIDE POINTS DOWN: full-year adjusted EBITDAX is guided $1,200M-$1,300M. With $642M booked in the first half, the back half implies about $608M - 5.3% BELOW the half just finished. Q3 alone is guided $285M-$325M vs the $338M just delivered. What was raised was efficiency: maintenance capital cut about 5% to $450M-$475M on six rigs, not seven.
What to watch: UP: Crimson closing in Q3 with the promised incremental guidance; adjusted EBITDAX per barrel recovering from $24.94; the hedge book rolling off toward the 95% of Brent CRC realizes unhedged. DOWN: a third quarter at the low end of the $285M-$325M guide, overhead per barrel rising above $6.57, or California permitting slowing 2027.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
YETI Holdings (YETI) Q2 2026 — Q2 2026 (13 weeks ended July 4; 8-K accepted 6:04am ET Aug 13, before the open, so Aug 13 is the reaction session): sales $483.9M up 8.5%, GAAP EPS $0.94 up 54%, adjusted EPS $0.67 against a $0.54 bar, guidance raised. The stock fell 10.56% that day on 4.6x volume and closed Aug 14 at $44.56.
YETI grew sales 8.5%, printed a 66.7% gross margin, raised guidance and reported EPS up 54%. The stock fell 10.6%. The reason is one line item: a $45.6M IEEPA tariff refund, about $0.40 a share, recognised in a single quarter. Strip it out and GAAP EPS is roughly $0.54 against $0.61 a year ago - and adjusted operating income FELL 6.8%.
THE CALL: HOLD (3/5, MODERATE - REAL BRAND, BROKEN OPERATING LEVERAGE) — base-case value ~$42.05 vs ~$44.56 today.
KEY METRICS:
- CALL: HOLD, 3/5. Fair value $41.28 against the $44.56 close on Aug 14, about 7% lower. Bear $32.40 ($2.70 at 12.0x), base $42.05 ($2.90 at 14.5x), bull $52.70 ($3.10 at 17.0x), weighted 30/50/20. Cross-checked on cash: durable free cash flow near $185M is $2.53 a share, a 6.1% yield at fair value and 5.7% at the close. The Street is Buy - 12 buy, 10 hold, 0 sell - with a $56.25 average target, 26% above the tape.
- THE QUARTER (13 weeks ended Jul 4, 2026): sales $483.868M, up 8.5%, essentially level with the $483.8M consensus. GAAP diluted EPS $0.94 against $0.61, up 54%. Adjusted EPS $0.67 against a $0.54 bar - a 24% beat, but only about +2% year over year. Adjusted operating income FELL 6.8% to $68.240M from $73.197M. Adjusted net income fell 8.2% to $50.685M. Diluted shares fell 9.2%, 83.462M to 75.782M.
- THE ANGLE - THE TARIFF REFUND IS THE HEADLINE: YETI concluded during the quarter that recovery of IEEPA tariffs was probable and booked a $45.6M net benefit - $42.6M as a reduction of cost of goods sold plus $2.9M of interest income. That is the whole of the 890 basis point gross margin gain (66.7% against 57.8%) and about $0.40 of GAAP EPS. Without it GAAP EPS is roughly $0.54 against $0.61 a year ago: down, not up 54%.
- THE OPERATING LEVERAGE INVERTED: sales added $37.976M. Adjusted gross profit added $30.522M. Adjusted SG&A added $35.479M. So adjusted operating income fell $4.957M - 80 cents of new gross profit against 93 cents of new operating cost, an incremental adjusted operating margin of -13.1%. Over the first half it is -20%: sales up $67.3M, adjusted operating income down $13.5M, margin 13.6% to 11.0%. Adjusted gross margin still rose 170bps to 59.5%.
- THE GUIDE AND WHAT IT REQUIRES: 2026 sales growth held at 7-8%; adjusted operating margin raised to 14.9% from 14.6%; adjusted EPS raised to $2.94-$3.00 from $2.83-$2.89; diluted shares cut to 75.4M from 76.6M; free cash flow held at $200M-$225M; capex $60M-$70M. That needs roughly $204M of second-half adjusted operating income against about $161M last year, up 27%, straight after a first half that fell 12.5%. The outlook assumes US tariffs return to about 20%.
- THE BALANCE SHEET AND THE RISKS: cash fell to $59.8M from $188.3M at the year end. First-half operating cash flow was $29.8M against $40.0M of property and intangible additions, so H1 free cash flow was negative $10.2M. YETI still spent $130.0M repurchasing 2.8M shares at about $46.43 and drew a net $30M on its revolver. Inventory $359.1M, up 23.6% since December. Drinkware, half the company, grew 2%; Coolers and Equipment grew 16%.
What to watch: UP: a September quarter where adjusted operating income grows rather than falls; free cash flow arriving on the guided path rather than through the tariff receivable; or a credible margin target at the September 17 Investor Day. DOWN: costs outrunning gross profit again, tariffs above the assumed 20%, or Drinkware stuck at 2%.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
Heartflow (HTFL) Q2 2026 — Q2 2026 (quarter ended June 30; 8-K accepted 4:02pm ET Aug 13, after the close, so Friday Aug 14 is the reaction): revenue $64.1M up 47.6% and 13.1% above consensus, non-GAAP loss $0.07 vs a $0.13 bar, full-year guidance raised to $246M-$250M. The stock closed Aug 14 at $42.08, up 35.70% on 9.91M shares - 9.0x its average volume.
Heartflow beat revenue by 13%, printed an 83.0% gross margin and raised full-year guidance by $18M. The stock gapped 35.7%. But subtract the $116.7M already booked in H1 from that raised guide and the second half implies just +1.6% sequential growth per quarter - one day after the company printed +21.9%.
THE CALL: AVOID (3/5, MODERATE - GREAT BUSINESS, FULLY PRICED) — base-case value ~$31.20 vs ~$42.08 today.
KEY METRICS:
- CALL: AVOID, 3/5. Fair value $31.20 vs the $42.08 close on Aug 14, about 26% lower. Bear $9.29, base $26.89, bull $50.06, weighted 15/55/30. The Street is Buy - 5 buy, 1 hold, 0 sell across 6 firms - with a $42.83 average target that is only 2% above the tape. Conviction is 3 not 4 because our own bull case is $50.06, and the business is genuinely excellent.
- THE QUARTER (3 months ended Jun 30, 2026): revenue $64.082M, up 47.6%, against a $56.635M consensus - a 13.1% beat. GAAP net loss $15.743M or $0.18/share; non-GAAP net loss $5.767M or $0.07/share against a $0.13 bar. The $9.976M bridge is $7.912M of stock compensation plus $2.064M of litigation expense. Adjusted EBITDA negative $6.7M vs negative $10.1M. US revenue $59.6M, up 51%.
- THE ANGLE - WHAT THE RAISED GUIDE ACTUALLY SAYS: H1 revenue was $116.669M. Full-year guidance is $246M-$250M, up from $228M-$232M. So H2 must be $129.3M-$133.3M. Solved as two equal sequential steps off the $64.082M just printed, that is +0.6% to +2.7% per quarter, or +1.6% at the midpoint - implying Q3 near $65.1M and Q4 near $66.2M. Sequential growth ran +6.6%, +6.2%, +7.0%, then +21.9%.
- WHAT THE MARKET REPRICED: enterprise value went from $2,442M to $3,402M, up 39.3%, while the full-year revenue midpoint went from $230M to $248M, up only 7.8%. The forward revenue multiple went 10.6x to 13.7x, up 29.2%. Decomposed, 77% of the move was multiple and 23% was the estimate change. On the $212.1M of revenue actually booked over four quarters the enterprise trades at 16.0x.
- THE UNIT ECONOMICS ARE REAL: gross margin 83.0% from 75.5%. Cost of revenue rose just 2.3% on revenue that rose 47.6%, so incremental gross margin was 98.8%. Non-GAAP operating margin improved 14.0 points, negative 26.4% to negative 12.4%. Break-even needs about $73.6M of quarterly revenue at frozen opex, 15% above this quarter. Cash and investments $246.8M with zero debt - roughly 4.2 years of runway.
- THE RISKS: in October 2025 Heartflow and certain employees received civil investigative demands from the DOJ under the federal Anti-Kickback Statute and Civil False Claims Act, aimed at its arrangements with providers and its sales and marketing. There are 11.7M potentially dilutive securities, 13.5% of the 86.7M shares. Three Form 144s covering 365,560 shares worth $15.3M were filed on Aug 14, the reaction day.
What to watch: UP: a September quarter clearing $65.1M with the full-year range raised a third time, proving the June step was a slope; or the DOJ civil investigative demand closing without action. DOWN: September landing on the guide, an adverse finding on provider arrangements, or the 11.7M dilutive overhang converting into the move.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
H&R Block (HRB) Q4 FY2026 — Q4 and full fiscal 2026 (ended June 30; 8-K accepted 4:10pm ET Aug 11, after the close, so Aug 12 is the reaction): Q4 adjusted EPS $2.38 vs a $2.21 bar, full-year revenue $3.95B up 4.9%. The stock gapped 16.1% to $54.18 and closed the week at $53.92.
H&R Block beat, raised its dividend a 9th straight year and guided FY2027 earnings up 15.6%. But the 10-K says total assisted tax return volume FELL 0.1% and DIY paid volume fell about 4%. All the growth was price, and the buyback supplied 47% of the earnings growth.
THE CALL: BUY (3/5, MODERATE - CHEAP, NOT RISKLESS) — base-case value ~$66.42 vs ~$53.92 today.
KEY METRICS:
- CALL: BUY, 3/5. Fair value $66.42 vs the $53.92 close on Aug 14, about 23% higher. Bear $43.95, base $69.12, bull $87.05, weighted 25/55/20. Street is a genuine Hold: 5 buy, 8 hold, 3 sell across 16 firms, target $46.50 - BELOW the tape, implying 14% downside. Conviction is 3 not 4: the bear case is a real 18% loss.
- THE QUARTER (3 months ended Jun 30, 2026): revenue $1,144.9M, up 3.0% vs a $1,118.0M consensus. Adjusted diluted EPS $2.38 vs a $2.21 bar - a 7.7% beat. GAAP continuing-ops EPS $2.31, consolidated GAAP $2.30. EBITDA $420.5M. The line nobody quoted: net income from continuing operations FELL, $300.4M to $294.5M. EPS rose anyway - the share count did it.
- THE FULL YEAR (FY2026): revenue $3,945.4M, up 4.9%. Net income from continuing ops $736.3M, up 20.8%. EBITDA $1,056.9M, up 8.3%. Adjusted net income $688.0M, up 6.9%. Adjusted EPS $5.31, up 14.0%. GAAP continuing EPS $5.69, up 28.7% - but that includes a one-time non-cash $84.1M IRS settlement benefit worth $0.65/share. Strip it and GAAP growth is 14.0%.
- WHERE THE GROWTH CAME FROM - the two 10-K sentences that decide this: U.S. assisted revenue rose $147.7M or 6.1%, from a 4.0% rise in NET AVERAGE CHARGE and 2.0% more COMPANY-OWNED volume. But total assisted return volume, company-owned AND franchise together, DECREASED 0.1%. DIY revenue rose 0.2% on a 4.2% price rise, so DIY paid volume fell ~4%. All growth was price; unit growth was zero.
- THE BUYBACK DID HALF THE WORK: adjusted net income rose 6.95%, adjusted EPS rose 13.95%. The 6.55-point gap is the denominator. HRB retired 10.5M shares, 7.9% of the company, for $500.3M at an average $47.48. Diluted shares fell 6.2%, 137.3M to 128.9M. The buyback supplied 47% of adjusted EPS growth; ~$600M is left on the $1.5B authorisation.
- THE CASH AND THE VALUATION: operating cash flow $838.7M, up 23.2%; capex only $82.6M. After $57.6M of franchise acquisitions, owner free cash flow is $698.4M - a 10.5% owner yield. Dividend raised 10% to $0.46/qtr, a 9th straight increase, 3.41% yield; $713.7M returned, a 10.7% shareholder yield. 123.3M shares off the 10-K cover, EV $7,179M: 8.8x guided FY2027 EPS, 6.4x guided EBITDA. Capitalise owner cash at 10% assuming it NEVER grows again: $52.34, roughly the share price.
What to watch: UP: total assisted return volume turning positive in March while net average charge still rises, plus a re-authorised buyback. DOWN: assisted volume down more than a point, charge growth under 3%, or free filing reaching assisted clients.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
StubHub Holdings (STUB) Q2 2026 — Q2 2026 (ended June 30; 8-K accepted 4:28pm ET Aug 12, after the close, so Aug 13 is the reaction): GMS $3.09B up 34%, revenue $573.1M up 33.2%, adjusted EBITDA $105.7M up 94%, diluted EPS to common $(0.00). The stock fell 10.1% to $7.68, printed $6.78 intraday, and closed the week at $8.08.
StubHub reported record GMS up 34%, revenue up 33%, adjusted EBITDA up 94%, and raised full-year volume guidance. The stock fell 10.1%. The reason is in the guidance: volume went up $200M, profit guidance did not move at all, and the raised range implies second-half volume growth of 0.2% to 4.3%.
THE CALL: SELL (4/5, A REAL MARKETPLACE AT A PRICE ITS OWN GUIDE DENIES) — base-case value ~$3.87 vs ~$8.08 today.
KEY METRICS:
- CALL: SELL, 4/5. Fair value about $3.87 vs the $8.08 close on Aug 14, roughly 52% lower. Bear $1.27, base $3.27, bull $9.30, weighted 30/50/20. Our BULL case is only 15% above the price. Street: 3 buy, 6 hold, 0 sell, target $10.75 - but no rating action post-dates this print. A valuation call, not a solvency call.
- THE QUARTER (ended Jun 30, 2026): GMS $3.09B, up 34% from $2.30B. Revenue $573.1M, up 33.2% against a $513.3M consensus - an 11.6% beat. Adjusted EBITDA $105.7M, up 94%, an 18% margin. Net income $14.6M vs a $53.8M loss. Diluted EPS to common is $(0.00): $14.6M of preferred dividends took the whole profit.
- THE GUIDANCE RAISE, READ CLOSELY: full-year GMS went from $9.9-10.1B in May up to $10.1-10.3B in August. Adjusted EBITDA guidance was $400-420M in May and is $400-420M in August - unchanged. Volume up $200M, profit up zero. At this quarter's take rate that $200M is worth about $37M of revenue.
- WHAT THE RAISED GUIDE IMPLIES: first-half GMS is already banked at $5.31B. Subtract it and second-half GMS has to land between $4.79B and $4.99B against $4.78B in 2H 2025 - growth of 0.2% to 4.3%. This quarter grew 34%; Q1 2026 grew 6.8%. The 10-Q credits the 34% to the World Cup by name.
- THE TAKE RATE WENT THE WRONG WAY: revenue was 18.55% of GMS this quarter against 18.71% a year ago, 19.05% across FY2025 and 20.40% across FY2024. Volume compounds while the fee take shrinks. The MD and A attributes growth to higher GMS per transaction - dearer tickets. FY2025 revenue fell 1.4%.
- WHAT ADJUSTED EBITDA LEAVES OUT: $69.0M of stock compensation expensed plus $27.7M capitalised into software equals $96.7M - 92% of the $105.7M adjusted EBITDA. Annualised at the first-half rate that is $269M against a $410M guide. Enterprise value of $4.47B on that guide less stock comp is 31.7 times.
- THE CASH AND THE STACK: of $1.69B of cash, $1.20B is money owed to sellers. TTM free cash flow of $597.6M contains $418.3M of float; ex-float it is about $179M. Ahead of a $3.09B market cap sit $930.9M of net debt and preferred carrying a $721.1M liquidation preference accruing about $60M a year.
What to watch: UP: a take rate back above 19.5% on the November print, gross stock compensation under $120M a year, and open distribution or advertising finally showing up in the other-revenue line. DOWN: a fourth quarter implied at flat or negative volume once the World Cup rolls out of the comparison.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
Kopin Corporation (KOPN) Q2 2026 — Q2 2026 (ended June 27; 8-K accepted 4:05pm ET Aug 10, after the close, so Aug 11 is the reaction): revenue $12.7M up 50.6%, loss from operations $3.5M, GAAP EPS $0.00 vs $(0.03), net income $0.83M. The stock rose 23.5% to $5.20 and closed the week at $5.50.
Kopin reported revenue up 51% and its first net income in years. The operating line still lost $3.5M: the profit is a $2.3M investment gain plus a $2.1M tax benefit from a statute of limitations expiring on Korean operations closed in 2018.
THE CALL: SELL (3/5, REAL TECHNOLOGY, ALL OF IT IN THE PRICE) — base-case value ~$2.66 vs ~$5.50 today.
KEY METRICS:
- CALL: SELL, 3/5. Fair value about $2.66 vs the $5.50 close on Aug 14, roughly 52% lower. Bear $0.67, base $2.41, bull $5.53 (30/45/25) on 2029 revenue of $70M/$130M/$220M at 2.5x/5.0x/7.0x EV-to-sales plus net cash. Our BULL case is 0.5% ABOVE the current price. Street: 5 buy, 2 hold, 0 sell, target $7.83. A valuation call, not a solvency call.
- THE QUARTER (ended Jun 27, 2026): revenue $12.7M vs $8.5M, up 50.6%. Loss from operations $3.50M vs $5.46M. Cost of product revenue 86% of product revenue vs 94%. R and D $4.52M vs $1.95M, but $3.33M of that is FUNDED and billed back out as revenue. GAAP EPS $0.00 vs $(0.03), and Kopin publishes no non-GAAP measure at all.
- WHERE THE GROWTH CAME FROM: revenue grew $4.28M, and $2.87M of that is NON-ASC-606 revenue that did not exist a year ago - $2.60M of government grant income and $0.27M of Fabric.AI collaboration income, 67% of the increase. ASC 606 growth is 16.7%, not 50.6%. PRODUCT revenue grew 1.9%, $7.50M to $7.64M.
- WHERE THE PROFIT CAME FROM: below the operating line. A $2.34M gain on investments took the pre-tax loss to $1.26M, then a $2.09M tax BENEFIT - a statute of limitations expiring on Korean operations liquidated in 2018 - made it $0.83M of net income. Ex both items EPS is $(0.0191) vs a $(0.0125) bar: a 53% MISS.
- THE PATTERN, NOT THE QUARTER: over the last four reported quarters Kopin booked $7.91M of cumulative GAAP net income on $15.08M of cumulative OPERATING LOSSES. The rescue item differed each time - litigation accrual, deconsolidation gain, investment marks, now a tax expiry. Trailing revenue $43.6M.
- THE CASH THAT IS NOT SPENDABLE: of $50.3M of cash and restricted cash, $24.2M collateralises the supersedeas bond posted Oct 2, 2025 for the appeal of the $19.7M BlueRadios judgment. 48% of balance-sheet cash is pledged to a court, and management's own 12-month liquidity assertion uses only the $24.9M unrestricted.
- VALUATION AND THE POSITIVES: 185,872,614 shares off the 10-Q cover at $5.50 is a $1.02B market cap, $997M EV, 22.9x trailing revenue - and 8.6x the $119.5M of 2030 revenue the SELL SIDE'S OWN model reaches. POSITIVES: H1 financing cash flow was NEGATIVE $1.10M, contract liabilities rose to $6.96M, no debt.
What to watch: UP: Drone Dominance volume orders that land in PRODUCT revenue, not grant income, plus a successful BlueRadios appeal releasing $24.2M. DOWN: another quarter where total revenue rises but product revenue stays near $7.6M.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.

Aug 15, 2026
Aug 15, 2026
14 min
York Space Systems (YSS) Q2 2026 — Q2 2026 (ended June 30; 8-K accepted 4:06pm ET Aug 13, after the close, so Aug 14 is the reaction): revenue $92.5M up 10.4%, gross margin 24% from 11%, GAAP loss per share $0.31. Full-year guidance cut from $545M-$595M to $375M-$405M. The stock fell 5.04% to $10.93.
York grew revenue 52% in 2025, IPO'd in January 2026, and guided the year to $545M-$595M - reaffirming it word for word on May 14. On August 13 it cut to $375M-$405M. Growth did not slow. It stopped.
THE CALL: SELL (3/5, REAL FRANCHISE, GROWTH GUIDE AT ZERO) — base-case value ~$9.43 vs ~$10.93 today.
KEY METRICS:
- CALL: SELL, 3/5. Fair value about $9.43 vs the $10.93 close on Aug 14, roughly 14% lower. Bear $6.38, base $9.33, bull $13.51 (25/55/20) on 2027 revenue of $430M/$500M/$650M at 1.5x/2.1x/2.5x EV-to-sales plus net cash. The Street disagrees: 4 buy, 3 hold, 0 sell across 7 firms, consensus target $33.38. A call on the revision cycle, not on solvency.
- THE QUARTER (ended Jun 30, 2026): revenue $92.5M, up 10.4% but DOWN 20.5% from Q1's $116.3M. Gross profit $22.2M vs $9.5M, a 24% margin against 11%; cost of revenue FELL 5.3%. GAAP loss per share $0.31 vs $0.25; York reports no adjusted EPS. Adjusted EBITDA minus $9.5M vs minus $8.9M - WORSE, because SG&A rose $15.0M, more than the entire $12.7M gross profit gain.
- THE GUIDANCE ROUND-TRIP: FY2026 revenue guidance was $545M-$595M on March 19, REAFFIRMED verbatim on May 14, then cut to $375M-$405M on August 13 - minus $180M at the midpoint (31.6%), and 30.1% below the $557.6M consensus. Against FY2025 actual revenue of $386.2M the new range is minus 2.9% to plus 4.9%, after York grew 52.3% in 2025.
- THE IMPLIED SECOND HALF: first-half revenue was $208.9M, so the guide leaves $166.1M-$196.1M for H2 against $196.1M in H2 2025 - minus 15.3% at the low end. At the VERY TOP of management's own range the implied second half is $196.110M against $196.112M a year ago: flat to within two thousand dollars. The best case in the range is no growth.
- WHY IT HAPPENED: 91% of Q2 revenue came from ONE customer, down from 96%. York became the first performer to COMPLETE its T1TL deliveries, putting 21 more satellites on orbit for a 42-for-42 record. The program that is essentially the whole revenue line is finished; follow-on work moves to IDIQ vehicles management concedes are slow to start. Backlog fell 7.8% to $592.0M.
- THE COVENANT NOBODY READS: the Nov 2025 credit agreement sets a MINIMUM REVENUE covenant, trailing twelve months, tested quarterly. The Dec 31, 2026 test is $372.5M, and at a calendar year end that figure IS full-year revenue. The low end of the new guide, $375.0M, clears it by 0.7%. The March-guide cushion was $197M; now $17.5M. NOT a default warning: equity cures and a leverage toggle exist; York was in compliance at June 30.
- THE CASH, AND WHO FUNDED THE WORK: contract liabilities - customer cash collected in advance - fell $110.3M to $18.2M. Roughly 51% of the $186.6M first-half operating burn was the float unwinding. Receivables went $11.5M to $55.8M, unbilled contract assets $76.8M to $115.0M. Cash was $534M at June 30, but All.Space took $155M out on July 8, so pro forma cash is about $379M, or $231M net of the term loan.
What to watch: UP: a funded task order York must quantify in a filing, or 2027 guidance above the $617.0M minimum-revenue level its lenders set. DOWN: another quarter of falling backlog with task orders unfunded.
Also on YouTube: @ChargedAlpha
DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Learn investing free in the Charged Alpha app: https://chargedalpha.com/app?source=youtube&ref=video
Educational only. Not financial advice.




